These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 32652570)
1. Molecular and functional characterization of urine-derived podocytes from patients with Alport syndrome. Iampietro C; Bellucci L; Arcolino FO; Arigoni M; Alessandri L; Gomez Y; Papadimitriou E; Calogero RA; Cocchi E; Van Den Heuvel L; Levtchenko E; Bussolati B J Pathol; 2020 Sep; 252(1):88-100. PubMed ID: 32652570 [TBL] [Abstract][Full Text] [Related]
2. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1. Madison J; Wilhelm K; Meehan DT; Delimont D; Samuelson G; Cosgrove D J Pathol; 2022 Sep; 258(1):26-37. PubMed ID: 35607980 [TBL] [Abstract][Full Text] [Related]
3. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice. Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390 [TBL] [Abstract][Full Text] [Related]
4. Bedside to bench Alport syndrome research: are human urine-derived podocytes the answer? Kim JJ; Fornoni A J Pathol; 2021 Jan; 253(1):11-13. PubMed ID: 33009821 [TBL] [Abstract][Full Text] [Related]
9. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome. Ding F; Wickman L; Wang SQ; Zhang Y; Wang F; Afshinnia F; Hodgin J; Ding J; Wiggins RC Kidney Int; 2017 Dec; 92(6):1515-1525. PubMed ID: 28754557 [TBL] [Abstract][Full Text] [Related]
10. Evidence for activation of the unfolded protein response in collagen IV nephropathies. Pieri M; Stefanou C; Zaravinos A; Erguler K; Stylianou K; Lapathitis G; Karaiskos C; Savva I; Paraskeva R; Dweep H; Sticht C; Anastasiadou N; Zouvani I; Goumenos D; Felekkis K; Saleem M; Voskarides K; Gretz N; Deltas C J Am Soc Nephrol; 2014 Feb; 25(2):260-75. PubMed ID: 24262798 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763 [TBL] [Abstract][Full Text] [Related]
12. Chemical chaperones to the rescue of Alport syndrome? Vanacore RM Kidney Int; 2024 Sep; 106(3):359-361. PubMed ID: 39174196 [TBL] [Abstract][Full Text] [Related]
13. Laminin-1 reexpression in Alport mouse glomerular basement membranes. Abrahamson DR; Prettyman AC; Robert B; St John PL Kidney Int; 2003 Mar; 63(3):826-34. PubMed ID: 12631063 [TBL] [Abstract][Full Text] [Related]
14. Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome. Daga S; Baldassarri M; Lo Rizzo C; Fallerini C; Imperatore V; Longo I; Frullanti E; Landucci E; Massella L; Pecoraro C; Garosi G; Ariani F; Mencarelli MA; Mari F; Renieri A; Pinto AM Hum Mutat; 2018 Feb; 39(2):302-314. PubMed ID: 29098738 [TBL] [Abstract][Full Text] [Related]
15. Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome. Ning L; Suleiman HY; Miner JH Am J Physiol Renal Physiol; 2021 Jul; 321(1):F12-F25. PubMed ID: 34029143 [TBL] [Abstract][Full Text] [Related]
16. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice. Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745 [TBL] [Abstract][Full Text] [Related]
17. Role of the podocyte (and glomerular endothelium) in building the GBM. Abrahamson DR Semin Nephrol; 2012 Jul; 32(4):342-9. PubMed ID: 22958488 [TBL] [Abstract][Full Text] [Related]